Monoclonal Antibody Therapy in Treating Patients With Leptomeningeal Cancer

Clinical trial NCT00003022 · COMPLETED

Trial details

NCT number: NCT00003022
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Intraocular Melanoma Lung Cancer Melanoma (Skin)Neuroblastoma Retinoblastoma Sarcoma

Start date: 1997-04-01
Primary completion: 2005-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.